National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 2) (PB 15 of 2020) (Cth)
PB 15 of 2020
National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 2)
National Health Act 1953
___________________________________________________________________________
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 27 February 2020
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Name of Instrument
(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 2).
(2)This Instrument may also be cited as PB 15 of 2020.
Commencement
This Instrument commences on 1 March 2020.
Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)
Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).
Schedule 1 Amendments
Schedule 1, entry for Levonorgestrel
insert as first entry:
| Intrauterine drug delivery system 19.5 mg | 20 | 1 | 0 |
Schedule 1, entry for Rivastigmine in the form Transdermal patch 27 mg
substitute:
| Transdermal patch 27 mg | 20 | 30 | 1 |
| 20 | 30 | 5 |
0
0
0